Annapolis Financial Services’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Annapolis Financial Services’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,078	Closed	-$96.3K	–	472
2023 Q4	$96.3K	Hold	1,078	–	–	0.02%	151
2023 Q3	$78.7K	Hold	1,078	–	–	0.02%	160
2023 Q2	$89.7K	Hold	1,078	–	–	0.03%	151
2023 Q1	$82.2K	Hold	1,078	–	–	0.02%	147
2022 Q4	$89.5K	Sell	1,078 -313	-23%	-$25.3K	0.03%	143
2022 Q3	$110K	Sell	1,391 -330	-19%	-$27.8K	0.04%	135
2022 Q2	$128K	Sell	1,721 -605	-26%	-$45.4K	0.05%	128
2022 Q1	$209K	Sell	2,326 -1,149	-33%	-$106K	0.07%	106
2021 Q4	$389K	Hold	3,475	–	–	0.12%	88
2021 Q3	$437K	Hold	3,475	–	–	0.15%	82
2021 Q2	$471K	Hold	3,475	–	–	0.16%	76
2021 Q1	$471K	Hold	3,475	–	–	0.17%	66
2020 Q4	$489K	Buy	+3,475	New	+$445K	0.19%	63

Other funds holding XBI

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Annapolis Financial Services's XBI Position: Q1 2024 in Review

Annapolis Financial Services sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2024, closing a stake of 1,078 shares — an estimated $96.3K sold.

Annapolis Financial Services first reported a position in XBI in Q4 2020 and held it in 13 quarters. The position peaked at $489K in Q4 2020. 782 funds tracked by Wall St. Rank hold XBI as of Q1 2024.

Annapolis Financial Services reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2024 after selling out during the quarter.
Annapolis Financial Services sold 1,078 State Street SPDR S&P Biotech ETF shares in Q1 2024, an estimated $96.3K.
Annapolis Financial Services first reported a position in State Street SPDR S&P Biotech ETF in Q4 2020 and held it in 13 quarters.
Annapolis Financial Services's State Street SPDR S&P Biotech ETF position peaked at $489K in Q4 2020.
782 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2024.

Based on Annapolis Financial Services's 13F filing for Q1 2024, filed 17 Apr 2024.